normative

Top-Down Pharma Planning Likely to Be Wrong

It is dangerous for an innovation-driven industry like pharma to impose top-down, pre-described views of what to invest in, because the industry is very likely to be wrong about which programs will succeed.

normativepending

Speaker

Alex

Evidence Quote

“it's quite dangerous in an industry like pharma, which is so innovation-driven and science-driven, to impose these top-down pre-described notions of what people should invest in.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...